February 2019 FDA Recall Tamsulosin Hydrochloride by Ascend Laboratories Llc
D-1066-2019 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Ascend Laboratories Llc on February 22, 2019 for the product Tamsulosin Hydrochloride. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1066-2019

Reason for Recall
Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.
Initiated
02-22-2019
Reported
03-13-2019
Quantity
3,072 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ascend Laboratories LLC
Nationwide in the USA and Puerto Rico.
Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.

Batch or Lot Expiration Information

Lot# : 8144652, Exp Jul 2020